5 Results for "

Lenvatinib (Standard)

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Lenvatinib (Standard)" in MCE Product Catalog:

Cat. No.: HY-10981R
CAS No.: 417716-92-8
Synonyms: E7080 (Standard)
Research Areas:  

Cancer

Lenvatinib (Standard) is the analytical standard of Lenvatinib. This product is intended for research and analytical applications. Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities .
loading...
    loading...
Cat. No.: HY-10981AR
CAS No.: 857890-39-2
Synonyms: E7080 mesylate (Standard)
Research Areas:  

Cancer

Lenvatinib (mesylate) (Standard) is the analytical standard of Lenvatinib (mesylate). This product is intended for research and analytical applications. Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities .
loading...
    loading...
Cat. No.: HY-133980AR
Research Areas:  

Cancer

Bamifylline (hydrochloride) (Standard) is the analytical standard of Bamifylline (hydrochloride). This product is intended for research and analytical applications. Bamifylline hydrochloride is a drug in the chemical class of xanthine that acts as a selective adenosine A1 receptor antagonist .
loading...
    loading...
Cat. No.: HY-W073260R
CAS No.: 417721-34-7
Target:  

Reference Standards

7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylic acid (Standard) is the analytical standard of 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylic acid. This product is intended for research and analytical applications.
loading...
    loading...
Cat. No.: HY-109056R
CAS No.: 868046-19-9
Synonyms: R-1206 (Standard)
Elsulfavirine (Standard) is the analytical standard of Elsulfavirine (HY-109056). This product is intended for research and analytical applications. Elsulfavirine (R-1206) is an orally active human carbonic anhydrase (carbonic anhydrase, CA) inhibitor and an allosteric inhibitor of HIV-1 non-nucleoside reverse transcriptase (NNRT). Elsulfavirine also targets and blocks the interaction between adenylosuccinate lyase (ADSL) and insulin-induced gene proteins INSIG1/2, blocks SREBP-1-mediated de novo lipid synthesis, and inhibits the proliferation of liver cancer cells. The combination of Elsulfavirine and Lenvatinib (HY-10981) produces a synergistic anti-tumor effect. Elsulfavirine is converted into the active metabolite VM1500A in vivo, blocks the DNA polymerase activity of reverse transcriptase, and inhibits HIV-1 replication. Elsulfavirine exhibits a Ki of 1960 nM-52400 nM against human carbonic anhydrase isoforms including I, VII, VI, VA, VB, IX, XIII, XIV. Elsulfavirine is used in studies related to HIV-1 infection and liver cancer .
loading...
    loading...